Shi-Hong Wen Selected Research

Shi-Hong Wen Research Topics

Disease

11	Ischemia 01/2023 - 05/2012
5	Reperfusion Injury 01/2023 - 07/2015
3	Neoplasms (Cancer) 06/2020 - 04/2008
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023
1	Mental Disorders (Mental Disorder) 10/2020
1	Necrosis 06/2020
1	Mesenteric Ischemia 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Pancreatitis 11/2019
1	Cardiac Arrhythmias (Arrythmia) 11/2018
1	Heart Failure 11/2018
1	Myocardial Infarction 11/2018
1	Pneumonia (Pneumonitis) 11/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2018
1	Acute Lung Injury 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Keratoconjunctivitis Sicca 01/2018
1	Dysbiosis 01/2016
1	Pathologic Constriction (Stenosis) 09/2014
1	Hypertension (High Blood Pressure) 12/2013
1	Delirium 12/2013
1	Lung Injury 04/2013
1	Brain Edema (Cerebral Edema) 08/2012
1	Neuroinflammatory Diseases 08/2012

Drug/Important Bio-Agent (IBA)

5	Dexmedetomidine FDA Link 01/2023 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 08/2012
3	salicylhydroxamic acid (SHAM)IBA 04/2013 - 08/2012
2	Yohimbine (Yocon)IBA 01/2023 - 05/2012
2	Remifentanil (Ultiva)FDA Link 02/2016 - 09/2014
2	Immunoglobulin A (IgA)IBA 01/2016 - 09/2015
2	Malondialdehyde (Propanedial)IBA 08/2012 - 05/2012
2	MatrinesIBA 05/2008 - 04/2008
1	statticIBA 01/2023
1	IsoenzymesIBA 01/2023
1	MB Form Creatine KinaseIBA 01/2023
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2020
1	TerlipressinIBA 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2018
1	TroponinIBA 11/2018
1	omega-Chloroacetophenone (Mace)IBA 11/2018
1	naltrindoleIBA 02/2016
1	phenylalanyl- cyclo(cysteinyltyrosyl- tryptophyl- ornithyl- threonyl- penicillamine)threoninamide (CTOP)IBA 02/2016
1	norbinaltorphimineIBA 02/2016
1	Opioid Receptors (Opioid Receptor)IBA 02/2016
1	ArginaseIBA 07/2015
1	Cathepsin BIBA 07/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2015
1	Anesthetics (Anesthetic Agents)IBA 09/2014
1	Propofol (Diprivan)FDA LinkGeneric 12/2013
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2013
1	Biomarkers (Surrogate Marker)IBA 04/2013
1	Aldehyde Reductase (Aldose Reductase)IBA 04/2013
1	epalrestatIBA 04/2013
1	EndotoxinsIBA 04/2013
1	Amine Oxidase (Copper-Containing)IBA 04/2013
1	Fatty Acid-Binding ProteinsIBA 04/2013
1	Sirolimus (Rapamycin)FDA Link 10/2012
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 10/2012
1	Janus KinasesIBA 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Caspase 3 (Caspase-3)IBA 08/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2012
1	CalciumIBA 08/2012
1	Superoxide DismutaseIBA 08/2012
1	Interleukin-6 (Interleukin 6)IBA 08/2012
1	Peroxidase (Myeloperoxidase)IBA 05/2012
1	VaccinesIBA 05/2008
1	antibiotic G 418IBA 04/2008

Therapy/Procedure

3	Perioperative Period 10/2020 - 05/2012
2	Ischemic Postconditioning 04/2013 - 10/2012
1	Ligation 01/2023
1	Hepatectomy 06/2020
1	Radiofrequency Ablation 06/2020
1	Resuscitation 11/2019
1	Length of Stay 11/2018
1	Autologous Transplantation 01/2018
1	Transplantation 01/2018
1	Analgesia 09/2014
1	Artificial Respiration (Mechanical Ventilation) 12/2013
1	Laparotomy 10/2012
1	Subcutaneous Injections 04/2008